The expression of the tetraspanin CD9, responsible for the maintenance of glioblastoma-like stem cells [32], and of CD81, associated with enhanced resistance to radiotherapy [33], is increased in low-grade gliomas and glioblastoma, respectively. This evidence concerns the gene CD81 and central nervous system cancer.